Infectious Diseases News and Research

RSS

Moderna's COVID-19 vaccine safe and effective in children 6 months to 5 years of age

Moderna's COVID-19 vaccine is safe and effective in children 6 months to 5 years of age, a clinical trial co-led by Vanderbilt University Medical Center vaccine expert C. Buddy Creech, MD, MPH, has found.

4 Nov 2022

What were the SARS-CoV-2 seroprevalence estimates for industrial livestock operation workers in the USA for 2021-2022?

In a new study, researchers measured SARS-CoV-2 seroprevalence in industrial livestock operation workers of North Carolina, United States, between February 2021 and July 2022.

4 Nov 2022

Researchers shed light on the key functions of innate immune cells

Inflammation and increased mucus production are typical symptoms of worm infections and allergies. This immune response involves our innate immune cells, but their exact functions are not yet fully understood.

3 Nov 2022

Bivalent mRNA booster broadens humoral immunity against SARS-CoV-2 Omicron subvariants

Researchers at Emory University, Stanford University, and the National Institute of Allergy and Infectious Diseases evaluated whether bivalent coronavirus disease 2019 (COVID-19) boosters conferred protection against new Omicron subvariants.

2 Nov 2022

Study suggests oral cephalosporins as safe, effective alternative for treating acute kidney infections

A new study led by Ochsner infectious diseases clinical pharmacist Kevin Lin, PharmD, was recently published in PLoS One, suggesting that oral cephalosporins are as safe and effective as the standard of care fluoroquinolones (FQs) for the treatment of acute kidney infections.

2 Nov 2022

Study calls for robust surveillance to detect unusual outbreaks in African countries

A new study has linked an invasive insecticide-resistant mosquito native to South Asia to an unprecedented urban outbreak of malaria in Ethiopia, the most compelling evidence to date that the mosquito, which is fast expanding its range, could cause infections to surge in areas of Africa with previously low rates of disease.

2 Nov 2022

Progress and challenges in the development of mRNA vaccines against respiratory syncytial virus

New research discussed the structure and life cycle of respiratory syncytial virus (RSV), the current research on the treatment and prevention of RSV infections, and the advancements in RSV mRNA vaccine technology after the surge in vaccine research during the COVID-19 pandemic.

1 Nov 2022

Rockefeller Foundation announces $3 million in new funding for Global.health

The Rockefeller Foundation has announced $3 million in new funding for Global.health (G.h) - a first-of-its-kind, open-source platform for scientific pandemic data.

1 Nov 2022

Cohort study determines how often COVID-19 symptoms recurred

Researchers at University of California San Diego School of Medicine, with colleagues from the ACTIV-2 trial, part of the U.S. government's response to COVID-19, investigated whether symptoms of COVID-19 recurred following a two-day symptom-free period in persons who did not receive any treatment for the disease.

1 Nov 2022

New nanovaccine greatly improves cytokine production

Cancer immunotherapies, such as immune checkpoint inhibition therapy, have been attracting attention in recent years as new methods for treating cancer. However, immune checkpoint inhibition therapy is only effective in 20%–30% of cancer patients, so developing better drug delivery systems to induce anticancer cellular immunity is necessary.

1 Nov 2022

Novel delivery system selectively delivers antibiotics to specific targets

Physicists at McMaster University have identified a natural delivery system which can safely carry potent antibiotics throughout the body to selectively attack and kill bacteria by using red blood cells as a vehicle.

1 Nov 2022

Monoclonal antibody shows efficacy in preventing malaria infection in African adults

One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa, a National Institutes of Health clinical trial has found.

31 Oct 2022

IHV researchers receive $7.5 million to control cancer among people living with HIV in sub-Saharan Africa

Institute of Human Virology researchers at the University of Maryland School of Medicine (UMSOM) have received two five-year awards from the National Institutes of Health's National Cancer Institute (NCI) for a total of $7.5 million.

31 Oct 2022

'What pediatricians need to know' about monkeypox in children

Children aged 8 years or younger should be considered a group at high risk for more severe monkeypox disease, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases.

28 Oct 2022

CU Anschutz study details the mechanisms behind the link between shingles and strokes

Scientists investigating why people who have had shingles are at a higher risk of stroke, now believe the answer lies within lipid vesicles called exosomes that shuttle proteins and genetic information between cells, according to new research from the University of Colorado Anschutz Medical Campus.

28 Oct 2022

New report highlights the health impacts of air pollution in Africa

Nearly all the African continent faces some of the most severe health impacts in the world caused by air pollution, with several countries experiencing some of the highest levels of air pollution in the world, according to a new report published by the U.S.-based research organization Health Effects Institute.

27 Oct 2022

Infectious Diseases News and Research

Moderna's COVID-19 vaccine safe and effective in children 6 months to 5 years of age

What were the SARS-CoV-2 seroprevalence estimates for industrial livestock operation workers in the USA for 2021-2022?

Researchers shed light on the key functions of innate immune cells

Bivalent mRNA booster broadens humoral immunity against SARS-CoV-2 Omicron subvariants

Study suggests oral cephalosporins as safe, effective alternative for treating acute kidney infections

Study calls for robust surveillance to detect unusual outbreaks in African countries

Progress and challenges in the development of mRNA vaccines against respiratory syncytial virus

Rockefeller Foundation announces $3 million in new funding for Global.health

Cohort study determines how often COVID-19 symptoms recurred

New nanovaccine greatly improves cytokine production

Novel delivery system selectively delivers antibiotics to specific targets

Monoclonal antibody shows efficacy in preventing malaria infection in African adults

IHV researchers receive $7.5 million to control cancer among people living with HIV in sub-Saharan Africa

'What pediatricians need to know' about monkeypox in children

CU Anschutz study details the mechanisms behind the link between shingles and strokes

New report highlights the health impacts of air pollution in Africa

UC San Diego participates in national trial to assess potential treatment for human monkeypox

Unprecedented COVID spikes could overwhelm local jurisdictions, mathematical model suggests

Lancaster University to be part of building malaria modeling capacity in Sub-Saharan Africa

Study shows the potential of experimental monoclonal antibodies to treat Epstein-Barr virus infection

Industry Focus: Infectious Diseases eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News